FDA Panel Backs Pfizer Vaccine, Some Worry About Including Teens In EUA

An overwhelming majority of FDA’s vaccine advisers on Thursday (Dec. 10) agreed that Pfizer’s vaccine is safe to authorize for emergency use, with 17 committee members voting that the benefits outweigh the risks. Of the four who voted “no” and the one member who abstained from voting, it seemed the main concern was that the emergency use authorization might apply to 16- and 17-year-olds, even though there are no data on use of the vaccine in teens. FDA likely will...